{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:13:44Z","timestamp":1782267224520,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ajic.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:46:50Z","timestamp":1696931210000},"page":"468-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Opioid exposure as a potential risk factor for vancomycin-resistant enterococci colonization in the absence of antimicrobial exposure"],"prefix":"10.1016","volume":"52","author":[{"given":"Parvathi","family":"Radhakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao F.G.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dombrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika M.C.","family":"D\u2019Agata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2023.10.001_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2023.10.001_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.aad9382","article-title":"Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens","volume":"352","author":"Pamer","year":"2016","journal-title":"Science."},{"key":"10.1016\/j.ajic.2023.10.001_bib3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciy358","article-title":"Acquisition of multidrug-resistant organisms in the absence of antimicrobials","volume":"67","author":"D'Agata","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.10.001_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1017\/ice.2019.208","article-title":"Acquisition of antimicrobial-resistant bacteria in the absence of antimicrobial exposure. A systematic review and meta-analysis","volume":"40","author":"D\u2019Agata","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2023.10.001_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/apt.14451","article-title":"Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications","volume":"47","author":"Le Bastard","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajic.2023.10.001_bib6","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/s41467-018-05184-7","article-title":"Gut microbiota associations with common diseases and prescription medications in a population-based cohort","volume":"9","author":"Jackson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajic.2023.10.001_bib7","unstructured":"World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification.\u00a0Accessed June 20, 2023. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification."},{"key":"10.1016\/j.ajic.2023.10.001_bib8","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/cid\/ciz626","article-title":"Predictors of Clostridioides difficile infection among asymptomatic, colonized patients: a retrospective cohort study","volume":"70","author":"Poirier","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2023.10.001_bib9","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1038\/s41598-018-21915-8","article-title":"Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajic.2023.10.001_bib10","doi-asserted-by":"crossref","first-page":"19471","DOI":"10.1038\/s41598-020-76570-9","article-title":"Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment","volume":"10","author":"Gicquelais","year":"2020","journal-title":"Sci Rep"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323006788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323006788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T09:12:28Z","timestamp":1710753148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655323006788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0196655323006788"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2023.10.001","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid exposure as a potential risk factor for vancomycin-resistant enterococci colonization in the absence of antimicrobial exposure","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}